Position in ACAD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$84,960,663
+$7,836,687 QoQ
Shares Held
3,358,129
-3.1% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. ACAD ranks #56 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,960,663 | 3,358,129 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $77,123,976 | 3,464,689 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $86,525,735 | 3,239,451 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $66,850,622 | 3,132,644 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $65,229,772 | 3,024,097 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $49,074,460 | 2,954,513 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $52,794,949 | 2,877,109 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $44,225,804 | 2,875,540 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $46,226,601 | 2,844,714 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $51,646,952 | 2,793,237 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $84,291,279 | 2,692,152 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $53,733,480 | 2,578,382 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $59,739,395 | 2,494,338 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $44,984,824 | 2,390,267 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $36,608,024 | 2,299,499 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $36,338,030 | 2,221,151 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,448,264 | 2,160,984 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $53,342,733 | 2,202,425 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $50,511,307 | 2,164,152 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $33,571,334 | 2,021,152 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $50,616,567 | 2,075,300 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $37,835,958 | 1,466,510 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $75,871,073 | 1,419,212 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $54,875,535 | 1,330,316 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $66,428,279 | 1,370,503 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $73,010,957 | 1,728,070 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||